amikacin has been researched along with Health Care Associated Infection in 197 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 70 (35.53) | 18.7374 |
| 1990's | 44 (22.34) | 18.2507 |
| 2000's | 45 (22.84) | 29.6817 |
| 2010's | 30 (15.23) | 24.3611 |
| 2020's | 8 (4.06) | 2.80 |
| Authors | Studies |
|---|---|
| Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
| Cauda, R; Citton, R; D'Inzeo, T; Fadda, G; Fiori, B; Montuori, E; Posteraro, B; Sanguinetti, M; Spanu, T; Trecarichi, EM; Tumbarello, M | 1 |
| Bonomo, RA; Endimiani, A; Hujer, AM; Hujer, KM; Luzzaro, F; Mantengoli, E; Migliavacca, R; Pagani, L; Rossolini, GM; Toniolo, A | 1 |
| Avlami, A; Daikos, GL; Katsilambros, N; Kosmidis, C; Petrikkos, G; Psychogiou, M; Stefanou, I; Tassios, PT; Vasilakopoulou, A | 1 |
| Castanheira, M; Jones, RN; Mendes, RE; Sader, HS; Toleman, MA; Walsh, TR | 1 |
| Chen, M; Guo, P; Sun, H; Wang, H; Xu, Y; Yang, Q; Zhu, Y | 1 |
| Bouza, E; Cercenado, E; Coll, P; Gutiérrez, O; Juan, C; Navarro, F; Oliver, A; Pérez, JL | 1 |
| Andres, P; Centrón, D; Galas, M; Guerriero, L; Petroni, A; Quiroga, C; Quiroga, MP; Soler Bistué, AJ; Tokumoto, M; Tolmasky, ME; Vargas, LJ; Zorreguieta, A | 1 |
| Carrillo, B; Esparza-Ahumada, S; Garza-Ramos, U; Hernández, E; Jones, RN; Morfin-Otero, R; Rodriguez-Noriega, E; Sader, HS; Sanchez, A; Silva-Sanchez, J | 1 |
| Badur, S; Cagatay, AA; Carrër, A; Eraksoy, H; Nordmann, P; Poirel, L | 1 |
| Afif, C; Bagattini, M; Daoud, Z; Di Popolo, A; Khan, AU; Triassi, M; Vitale, D; Zarrilli, R | 1 |
| Adams-Haduch, JM; Doi, Y; Harrison, LH; Muto, CA; Pasculle, AW; Paterson, DL; Potoski, BA; Sidjabat, HE | 1 |
| Acosta, J; Chaves, F; Juan, C; Oliver, A; Otero, JR; Sanz, F; Viedma, E; Zamorano, L | 1 |
| Chen, H; Chen, M; Sun, H; Wang, H; Xu, Y; Yang, Q | 1 |
| Badal, RE; Baquero, F; Bouchillon, SK; Cantón, R; Hawser, SP; Hoban, DJ | 1 |
| Gebrecherkos, T; Mekonnen, H; Molla Fenta, G; Seid, A | 1 |
| Li, S; Liu, W; Mo, Q; Shao, M; Sun, L; Ying, N; Zhu, L | 1 |
| De Vito, D; Fruscio, G; Garrisi, VM; Hall, GG; Laforgia, M; Nardulli, P; Quarta, A; Ruggiero, R; Scacco, S | 1 |
| Ge, H; Li, N; Yan, L; Zhang, Y | 1 |
| Adeleke, G; Egbagbe, E; Ejembi, J; Ettu, AO; Habib, A; Irowa, OO; Makanjuola, OB; Medugu, N; Mutiu, B; Ogunbosi, B; Ogunsola, F; Oladele, RO; Osinaike, T; Rotimi, V; Uwaezuoke, NS | 1 |
| Cabot, G; Fernández-Cuenca, F; López-Cerero, L; López-Méndez, J; Oliver, A; Pascual, Á; Portillo, I; Recacha, E; Rodríguez-Baño, J | 1 |
| Nambiar, S; Schumann, K; Walinsky, S | 1 |
| Alp, E; Çetin, M; Elmali, F; Kaynar, L; Kürkçüoglu, CA; Metan, G; Yozgat, N | 1 |
| Arnaud, E; Larcher, R; Lavigne, JP; Pantel, A; Sotto, A | 1 |
| Abbassi, MM; Awdallah, FF; Hassan, NA; Sabry, NA | 1 |
| Javadi, A; Kazemian, H; Kodori, M; Monfared, MRZ; Rad, MR; Rahdar, H; Yazdani, F | 1 |
| Fernández Esgueva, M; Ferrer Cerón, I; García-Lechuz Moya, JM; López-Calleja, AI; Morilla Morales, E; Nuñez Medina, R; Rezusta López, A; Sahagún Pareja, J; Viñuelas Bayon, J | 1 |
| Abou El-Khier, NT; Rizk, MA | 1 |
| Chen, Y; Liu, L | 1 |
| Buntaran, L; Dwiyanti, R; Hatta, M; Sabir, M; Sultan, AR | 1 |
| Alba, L; Clock, SA; Kubin, CJ; Saiman, L; Tabibi, S; Whittier, S | 1 |
| Athanasiou, S; Falagas, ME; Tansarli, GS | 1 |
| Alba, L; Behta, M; Clock, SA; Della-Latta, P; Furuya, EY; Jenkins, SG; Jia, H; Kubin, CJ; Oliveira, AP; Patel, SJ; Rhee, K; Saiman, L; Schuetz, AN; Weisenberg, SA; Whittier, S; Zhou, JJ | 1 |
| Dudek, M; Romanowska, J; Trylska, J; Wituła, T | 1 |
| Culebras, E; García-Salguero, C; Picazo, JJ; Rodríguez-Avial, I | 1 |
| Chang, SC; Ho, MW; Hseuh, PR; Lee, CH; Liu, JW; Liu, JY; Sheng, WH; Wang, FD; Wang, JT | 1 |
| Barišić, Z; Goic-Barisic, I; Hrenović, J; Kaliterna, M; Kaliterna, V; Tonkić, M | 1 |
| Asai, S; Inokuchi, S; Iwashita, H; Kaneko, A; Miyachi, H; Ohashi, M; Ohshima, T; Sasaki, M; Umezawa, K | 1 |
| Badal, RE; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S | 1 |
| Badal, RE; Hackel, MA; Lob, SH; Sahm, DF | 1 |
| Nicolau, DP; Sutherland, CA; Verastegui, JE | 1 |
| Badal, RE; Biedenbach, DJ; Giao, PT; Hung Van, P; Phuong, DM; Su Minh Tuyet, N; Thi Thanh Nga, T; Vu Trung, N | 1 |
| Alonso-Isa, M; Benítez-Sala, R; García-Rojo, E; Gil-Moradillo, J; González-Padilla, DA; Justo-Quintas, J; Lara-Isla, A; Medina-Polo, J; Passas-Martínez, JB; Sopeña-Sutil, R; Tejido-Sánchez, Á | 1 |
| Alp, E; Badal, R; Gulay, Z; Koksal, I; Korten, V; Lob, S; Mete, B; Mulazimoglu, L; Oguz, VA; Tabak, F; Unal, S; Yilmaz, G; Zarakolu, P | 1 |
| Chaudhary, M; Sehgal, R; Shrivastava, SM; Varughese, L | 1 |
| Hsieh, FC; Lee, CM; Leung, CH; Liu, CP; Wang, NY; Weng, LC | 1 |
| Adebiyi, OE; Alli, AO; Daini, OA; Ogbolu, DO; Ogunledun, A; Terry, AO | 1 |
| Ermertcan, S; Hosgor-Limoncu, M; Tasli, H; Yurtman, AN | 1 |
| Chastre, J; Clavel, M; Corkery, K; Gribben, D; Guntupalli, K; Johannigman, J; Kennedy, JI; Luyt, CE; Wood, C | 1 |
| Bautista, V; Campos, J; Fernández, S; Gil-Antón, J; Hernández-Almaraz, JL; Oteo, J; Vindel, A | 1 |
| Aysev, D; Doğu, F; Erol Cipe, F; Ikincioğulları, A; Sucuoğlu, D | 1 |
| Doi, M; Kobayashi, K; Koda, S; Kumon, H; Kusano, N; Kuwabara, M; Shimizu, E; Shimizu, W; Sugai, M | 1 |
| Chong, Y; Hong, HL; Jeong, SH; Kang, JO; Kim, JS; Kim, MN; Lee, K; Park, YJ; Shin, JH; Yong, D | 1 |
| Aboussad, A; Chabaa, L; Elidrissi, NS; Issaoui, S; Maoulainine, FM; Sorra, N | 1 |
| Cheng, A; Hsueh, PR; Huang, YT; Lee, YC; Liao, CH; Liu, CY; Tsai, HY | 1 |
| Budak, A; Paluchowska, P; Skałkowska, M; Spelak, A | 1 |
| Dudzevicius, V; Sakalauskas, R; Vitkauskiene, A | 1 |
| Benomar, S; Bouharrou, A; Habzi, A; Lahbabi, M; Najdi, T; Nejjari, N; Zerhouni, F | 1 |
| Martin, JE | 1 |
| Adamidou, M; Bacopoulou, F; Markantonis, SL; Pavlou, E | 1 |
| Berger, A; Gludovatz, P; Haiden, N; Heinze, G; Kretzer, V; Pollak, A | 1 |
| Friedland, I; Gallagher, G; King, T; Woods, GL | 1 |
| Bello, HT; Díaz, PQ; Domínguez, MY; González, GR; Mella, SM; Trabal, NF; Zemelman, RZ | 1 |
| Devi, NA; Doss, VA; Parvathi, S; Raju, BA | 1 |
| Antonopoulou, A; Giamarellos-Bourboulis, EJ; Giamarellou, H; Kentepozidis, N; Plachouras, D; Tsaganos, T | 1 |
| Kaczala, G; McDougall, J; Nelle, M; Slongo, T | 1 |
| Ho, SW; Hsueh, PR; Teng, LJ; Tseng, SP | 1 |
| Almirante, B; Calleja, R; Fernandez-Hidalgo, N; Pahissa, A; Pigrau, C; Planes, AM; Rodriguez, D; Ruiz, I | 1 |
| Cicek, A; Durmaz, R; Kuzucu, C; Otlu, B; Yetkin, G | 1 |
| Lefor, AT; Morita, R; Nabeshima, T; Yoshida, M | 1 |
| Ayyagari, A; Dash, NR; Ghar, M; Nag, VL; Prasad, KN; Venkatesh, V | 1 |
| Badaró, R; Noblat, AC; Noblat, L; Oliveira, MG; Santos-Jesus, R | 1 |
| Bilewska, A; Luczak, M; Młynarczyk, A; Młynarczyk, G; Pupek, J | 1 |
| Bhat, S; Capitano, B; Fujitani, S; Linden, PK; Paterson, DL; Potoski, BA; Shutt, K | 1 |
| Benslama, A; Charra, B; Hachimi, A; Motaouakkil, S | 1 |
| Coombe, RG; George, AM | 1 |
| Fleming, PJ; Hawkey, PM; Lewis, DA; Pitt, TL; Primavesi, RJ; Speller, DC | 1 |
| Cohen, T; Drucker, M; Reisner, SH; Wielunsky, E | 1 |
| Alegente, G; Marchi, B; Pieri, I; Progenie, G; Rubino, M; Saturni, A | 1 |
| Betts, RF; Chapman, SW; Chonmaitree, T; Messner, M; Mowrer, G; Pincus, P; Robertson, R; Valenti, WM | 1 |
| Cavanagh, HD; Finton, RJ; Goodman, RA; Newman, PE; Waring, GO; Wilson, LA; Wright, J | 1 |
| Gruensfelder, R; Kabins, SA; Nathan, C; Weinstein, RA | 1 |
| Duncan, IB; Duncan, NH; Rennie, RP | 1 |
| Cook, LN; Davis, RS; Stover, BH | 1 |
| Casewell, M; Dacey, S; Datta, N; Hughes, V; Knight, S; Richards, H; Shannon, KP; Williams, G | 1 |
| Arvin, AM; Prober, CG; Yeager, AS | 1 |
| Cheung, EY; Duncan, IB; Haldane, EV; Jackson, FL; McNaughton, RD; Morisset, RA; Noble, MA; Rennie, RP; Ronald, AR; Smith, JA | 1 |
| Farchione, LA; Karpow, SA; Kresel, PA; Price, KE; Siskin, SB | 1 |
| Griffin, E; Mulhern, B | 1 |
| Flournoy, DJ; Perryman, FA | 1 |
| Abelha, F; Menezes, MR; Pimentel, FL; Sá, LV; Trigo, MA | 1 |
| García, DC; Kaufman, S; Piñeiro, S; Sordelli, DO; Woloj, GM | 1 |
| Wang, F; Wang, YQ; Zhu, DM | 1 |
| Harris, SP; Muder, RR; Nguyen, MH; Pasculle, AW | 1 |
| de Champs, C; Franchineau, P; Gaulme, J; Gourgand, JM; Loriette, Y; Sirot, J | 1 |
| Kahr, A; Michéa-Hamzehpour, M; Pechère, JC | 1 |
| Sanders, CV | 1 |
| Godard, C; Hannecart-Pokorni, E; Hubrechts, JM; Maes, P; Nulens, E; Nyssen, HJ; Vanhoof, R; Wildemauwe, C | 1 |
| Can, G; Coban, A; Ince, Z; Ozgeneci, A; Uçsel, R | 1 |
| Albanese, J; Domart, Y; Durbec, O; Gouin, F; Grès, JJ; Leroy, J; Martin, C; Papazian, L; Rollin, C; Veyssier, P | 1 |
| Martínez, MA; Pinto, ME | 1 |
| Tang, Y; Wu, SX | 1 |
| Balslev, T; Ebbesen, F; Korsager, B; Kristensen, B; Schumacher, H | 1 |
| Lundberg, S; Massad, E; Yang, HM | 1 |
| Beuscart, C; Mouton, YJ | 1 |
| Colardyn, F | 1 |
| Beaucaire, G | 1 |
| Bello, H; Dominguez, M; Garcia, A; Gonzalez, G; Mella, S; Zemelman, R | 1 |
| Cuccia, A; O'Riordan, TG; Palmer, LB; Simon, SR; Smaldone, GC | 1 |
| Eltahawy, AT | 1 |
| Derevianko, II; Iakovlev, SV; Iakovlev, VP; Kira, EF | 1 |
| Izard, D; Vachée, A; Vincent, P | 1 |
| Ballanger, P; Ragnaud, JM; Tauzin-Fin, P | 1 |
| Beaucaire, G; Holzapfel, L; Le Fur, D; Léophonte, P; Martin, C; Nicolas, MH; Offenstadt, G; Péan, Y; Philippon, A; Renard, S | 1 |
| Alimena, G; Battistini, R; Breccia, M; Celesti, F; Cimino, G; Coppola, L; Girmenia, C; Latagliata, R; Mandelli, F; Morano, SG; Spadea, A; Tafuri, A; Tosti, S | 1 |
| Dalton, D; Eagles, G; Gilbert, G; Halasz, S; Isaacs, D; Jelfs, P; Royle, J | 1 |
| Midani, S; Rathore, MH | 1 |
| Bacci, S; Bosi, A; Fanci, R; Guidi, S; Laszlo, D; Rossi-Ferrini, P; Saccardi, R; Vannucchi, AM | 1 |
| Kaiser, AM; Koeleman, JG; Parlevliet, GA; Savelkoul, PH; Stoof, J; van der Zwet, WC; Vandenbroucke-Grauls, CM | 1 |
| Zafar, A | 1 |
| O'Connell, M; Petros, AJ; Roberts, C; van Saene, HK; Wade, P | 1 |
| Abi-Said, D; Bivins, C; Hachem, R; Hanna, H; Huaringa, A; Raad, I; Sukumaran, A; Thornby, J; Walsh, G; Whimbey, E | 1 |
| Alvarez-Lerma, F; Barcenilla, F; Insausti-Ordeñana, J; Jordá-Marcos, R; Maraví-Poma, E; Martínez-Pellús, A; Nava, J; Palomar, M; Torres-Martí, A | 1 |
| Andre, C; Arpin, C; Dubois, V; Frigo, C; Melon, B; Melon, M; Quentin, C | 1 |
| Gadba, R; Ofir, O; Samra, Z | 1 |
| Gupta, A; Ray, P; Sethi, S; Sharma, M; Singh, M | 1 |
| Berger, R; Gruenewald, T; Leibovici, L; Milo, G; Paul, M; Pitlik, SD; Samra, Z; Yahav, J; Yehezkelli, Y | 1 |
| Jin, D; Wu, H; Wu, Z; Xu, J | 1 |
| Alvarez Lerma, F | 1 |
| Halter, J; Lewis, RP; Meyer, RD; White, M | 1 |
| Blech, MF; Hartemann, P; Imbs, MA | 1 |
| Craven, PC; Drutz, DJ; Jorgensen, JH; Kaspar, RL | 1 |
| Bint, AJ; Speller, DC; Stephens, M | 1 |
| Greenman, RL; Hoffman, TA; Sklaver, AR | 1 |
| Moellering, RC; Murray, BE | 1 |
| Nathan, DM; Thiemke, WA | 1 |
| Tsujimoto, T; Yama, H; Yamada, K | 1 |
| Alford, RH; Leonard, JM; McGee, ZA | 1 |
| Folb, PI | 1 |
| Leidenfrost, U; Nöske, HD; Schröder, R; Sziegoleit, A; Weidner, W | 1 |
| Gailliard, MC; Kazmierczak, A; Portier, H; Pothier, P; Siebor, E | 1 |
| Acar, JF; Christol, D; Golstein, FW; Pangon, B; Witchitz, JL | 1 |
| Brunel, D; Despaux, E; Hichri, H; Michel, D; Rodiere, M | 1 |
| Canton, Ph; Dureux, JB; Etienne, Y; Neiman, L | 1 |
| Spaepen, J; Vandepitte, J; Verbist, L | 1 |
| Marget, W; Reindke, B; Versmold, H | 1 |
| Guerrant, RL; Hamory, BH; Sande, MA; Strausbaugh, LJ; Wenzel, RP | 1 |
| Doughty, SC; Greenberg, SB; Martin, RR | 1 |
| Bartlett, JG | 1 |
| Yow, MD | 1 |
| Grunert, K; Koeppe, P; Langmaack, H; Lode, H | 1 |
| Eickhoff, TC; Iannini, PB; LaForce, FM | 1 |
| Bhana, RH; Coovadia, YM; George, RC; Hafferjee, IE; Hutchinson, GR; Johnson, AP | 1 |
| Clément, C; Demingeon, G; Holzapfel, L; Madinier, G; Ohen, F; Villette, P | 1 |
| Casiraghi, S; Caspani, P; Germiniani, R; Pace, M; Rosina, M; Tajana, A; Trabucchi, E | 1 |
| da Silva, FC | 1 |
| Akalin, HE; Gür, D; Kocagöz, T | 1 |
| Franzus, B; Sarubbi, F; Verghese, A | 1 |
| del Pilar Pla, M; Flores, A; Hopkins, JD; Lester, S; O'Brien, TF | 1 |
| Branger, C; Le Mée, J | 1 |
| Beaucaire, G; Beuscart, C; Caillaux, M; Chidiac, C; Karp, P; Leroy, O | 1 |
| Brandimarte, C; De Vincentiis, M; Fusconi, M; Gelfusa, V; Serra, P; Turchetta, R; Venditti, M | 1 |
| Bouvet, P; Buisson, Y; Driot, L; Ginot, L; Meyran, M; Schill, H; Tran Van Nhieu, G | 1 |
| Bale, MJ; Doebbeling, BN; Pfaller, MA; Wenzel, RP | 1 |
| Jia, CY | 1 |
| Adhikari, M; Coovadia, YM; Mayosi, B; Solwa, Z; van den Ende, J | 1 |
| Gómez-Garcés, JL; Rodriguez-Tudela, JL; Soriano, F; Velo, M | 1 |
| Noone, M; Noone, P; Pomeroy, L; Sage, R | 1 |
| Agusti Vidal, A; Almela, M; de Celis, R; Deulofeu, R; Marco, F; Rabinad, E; Rodriguez-Roisin, R; Torres, A | 1 |
| Ramirez-Ronda, CH; Rivera-Vazquez, CR; Rodriguez, JR; Saavedra, S | 1 |
| Beuscart, C; Drugeon, H; Leroy, O; Mouton, Y; Pappo, M | 2 |
| Kua, LT; Limson, BM; Litam, P; Navarro-Almario, E; Que, E | 1 |
| Ansquer, M; Brun-Buisson, C; Duval, J; Legrand, P; Montravers, F; Philippon, A | 1 |
| Rahal, JJ; Simberkoff, MS | 1 |
| Hindler, J; Young, LS | 1 |
| Gerding, DN; Larson, TA | 1 |
| Bobadilla, M; Calva, JJ; Huazano, F; Ojeda, F; Ontiveros, C; Ponce de Leon, S; Ruiz-Palacios, GM; Sifuentes, J | 1 |
| Falagas, M; Giamarellou, H; Kanellakopoulou, K; Koratzanis, G; Lelekis, M; Pagona, A; Petrikkos, G; Symeonides, J; Touliatou, K; Tsagarakis, J | 1 |
| Baratta, E; Bucaneve, G; Del Favero, A; Grignani, F; Menichetti, F; Pasticci, MB; Patoia, L | 1 |
| Havlík, J; Kettner, M; Krcméry, V; Macicková, T; Navarová, J | 1 |
| McCracken, GH; Odio, CM; Saenz, A; Salas, JL; Umana, MA | 1 |
| Buisson, Y; Levagueresse, R; Meyran, M; Saliou, P; Santiago, M; Thabaut, A | 1 |
| Mylotte, JM | 1 |
| Kedzia, W; Mirkska, I; Zawieja, M | 1 |
| Crosa, JH; Roberts, MC; Tolmasky, ME; Woloj, M | 1 |
| Calandra, T; Casey, PA; Glauser, MP; Meylan, PR | 1 |
| Antonioni, M; De Cristofaro, A; Mergoni, M; Stocchetti, N; Zuccoli, P | 1 |
| Aulicino, TM; Gombert, ME | 1 |
| Holloway, WJ | 1 |
| Childs, SJ | 1 |
| King, A; Phillips, I; Shannon, K | 1 |
| Chao, HP; Guenthner, SH; Wenzel, RP | 1 |
| Claeys, M; Hubrechts, JM; Nulens, E; Nyssen, HJ; Roebben, E; Van Gysel, JP; Van Haeverbeek, M; Vanhoof, R | 1 |
| Lee, JT | 1 |
| Carson, CC; Paulson, DF; Rudd, C | 1 |
| Clarridge, JE; Koza, MA; Sewell, CM; Young, EJ | 1 |
5 review(s) available for amikacin and Health Care Associated Infection
| Article | Year |
|---|---|
Epidemiology of pathogens and antimicrobial resistance of nosocomial urinary tract infections in patients with spinal cord injuries in China: A systematic review and meta-analysis.
Topics: Amikacin; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Humans; Levofloxacin; Spinal Cord Injuries; Urinary Tract Infections | 2023 |
Evaluation of antimicrobial susceptibility of Enterobacteriaceae causing urinary tract infections in Africa.
Topics: Africa; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Cross Infection; Databases, Factual; Drug Evaluation; Enterobacteriaceae; Enterobacteriaceae Infections; Fosfomycin; Humans; Microbial Sensitivity Tests; Prevalence; Urinary Tract Infections | 2013 |
Mycobacterium fortuitum infection of ventriculoperitoneal shunt.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Causality; Central Nervous System Infections; Cross Infection; Debridement; Drainage; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Male; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Trimethoprim, Sulfamethoxazole Drug Combination; Ventriculoperitoneal Shunt | 1999 |
[Serratia, cause of nosocomial infections and its occurrence in the patient's environment (author's transl)].
Topics: Air Microbiology; Amikacin; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae Infections; Epidemiologic Methods; Erythromycin; Gentamicins; Humans; Lincomycin; Polymyxins; Serratia marcescens; Sisomicin; Soil Microbiology; Tetracyclines; Tobramycin; Water Microbiology | 1979 |
Patterns and mechanisms of antibiotic resistance.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacteria; beta-Lactamases; Cell Membrane Permeability; Cross Infection; Drug Resistance, Microbial; Escherichia coli; Genetics, Microbial; Gentamicins; Humans; Penicillin Resistance; R Factors; Salmonella; Shigella; Staphylococcus aureus; Tobramycin; Translocation, Genetic | 1978 |
30 trial(s) available for amikacin and Health Care Associated Infection
| Article | Year |
|---|---|
Nebulized Versus IV Amikacin as Adjunctive Antibiotic for Hospital and Ventilator-Acquired Pneumonia Postcardiac Surgeries: A Randomized Controlled Trial.
Topics: Administration, Inhalation; Adult; Amikacin; Cross Infection; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Multiple; Female; Gram-Negative Bacterial Infections; Heart Diseases; Humans; Infusions, Intravenous; Length of Stay; Male; Middle Aged; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Postoperative Complications; Prospective Studies; Treatment Outcome | 2018 |
Efficacy and safety evaluation of fixed dose combination of cefepime and amikacin in comparison with cefepime alone in treatment of nosocomial pneumonia patients.
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Cross Infection; Drug Combinations; Female; Humans; Injections, Intravenous; Male; Middle Aged; Pneumonia, Bacterial; Pseudomonas Infections; Treatment Outcome | 2008 |
A study of once-daily amikacin with low peak target concentrations in intensive care unit patients: pharmacokinetics and associated outcomes.
Topics: Acinetobacter Infections; Adult; Amikacin; Anti-Bacterial Agents; Area Under Curve; Creatinine; Cross Infection; Drug Administration Schedule; Drug Therapy, Combination; Female; Half-Life; Humans; Infusions, Intravenous; Intensive Care Units; Male; Metabolic Clearance Rate; Prospective Studies; Pseudomonas Infections; Superinfection | 2003 |
Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Anticoagulants; Bacteremia; Blood; Catheterization, Central Venous; Catheters, Indwelling; Ciprofloxacin; Colony Count, Microbial; Cross Infection; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Heparin; Humans; Male; Middle Aged; Vancomycin | 2006 |
Implementation and evaluation of a once-daily amikacin dosing protocol in a long-term care facility.
Topics: Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Body Temperature; C-Reactive Protein; Creatinine; Cross Infection; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Health Facilities; Humans; Injections, Intramuscular; Injections, Intravenous; Kidney Function Tests; Leukocyte Count; Long-Term Care; Male; Respiratory Tract Infections; Treatment Outcome | 2007 |
Piperacillin/tazobactam in the treatment of community-acquired and nosocomial respiratory tract infections: a review.
Topics: Adult; Aged; Amikacin; beta-Lactamase Inhibitors; Community-Acquired Infections; Cross Infection; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Respiratory Tract Infections; Tazobactam | 1994 |
A non-comparative study of the efficacy and tolerance of cefepime in combination with amikacin in the treatment of severe infections in patients in intensive care.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacteremia; Bacterial Infections; Cefepime; Cephalosporins; Critical Care; Cross Infection; Drug Therapy, Combination; Female; Follow-Up Studies; France; Humans; Male; Middle Aged; Respiratory Tract Infections; Shock, Septic | 1993 |
Empirical monotherapy with meropenem in serious bacterial infections. Meropenem Study Group.
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Carbapenems; Ceftazidime; Community-Acquired Infections; Cross Infection; Drug Therapy, Combination; Drug Tolerance; Hospitalization; Humans; Meropenem; Middle Aged; Respiratory Tract Infections; Sepsis; Thienamycins; Time Factors; Treatment Outcome; Urinary Tract Infections | 1995 |
The efficacy and safety of isepamicin and ceftazidime compared with amikacin and ceftazidime in acute lower respiratory tract infection.
Topics: Acute Disease; Amikacin; Anti-Bacterial Agents; Bronchitis; Ceftazidime; Cross Infection; Drug Administration Schedule; Drug Therapy, Combination; Female; Gentamicins; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Pneumonia, Bacterial; Respiratory Tract Infections; Retrospective Studies | 1995 |
Evaluation of the efficacy and safety of isepamicin compared with amikacin in the treatment of nosocomial pneumonia and septicaemia.
Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Cross Infection; Drug Therapy, Combination; Female; Gentamicins; Gram-Negative Bacterial Infections; Humans; Lactams; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies | 1995 |
Aerosolized antibiotics in mechanically ventilated patients: delivery and response.
Topics: Adult; Aerosols; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Case-Control Studies; Chronic Disease; Colony Count, Microbial; Cross Infection; Cytokines; Gentamicins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intercellular Adhesion Molecule-1; Male; Nebulizers and Vaporizers; Prospective Studies; Respiration, Artificial; Respiratory Insufficiency; Respiratory Tract Infections; Sputum; Trachea; Tracheostomy | 1998 |
[Multicenter open randomized trial of meropenem in comparison to ceftazidime and amikacin used in combination in severe hospital infections].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Ceftazidime; Cross Infection; Drug Therapy, Combination; Female; Humans; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Thienamycins; Treatment Outcome | 1998 |
[Phare study. Comparative study of combined cefepime-amikacin versus ceftazidime combined with amikacin in the treatment of nosocomial pneumonias in ventilated patients. Multicenter group study].
Topics: Amikacin; Cefepime; Ceftazidime; Cephalosporins; Cross Infection; Double-Blind Method; Drug Therapy, Combination; Female; France; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Middle Aged; Pneumonia, Bacterial; Respiration, Artificial; Survival Rate | 1999 |
An open evaluation of triple antibiotic therapy including vancomycin for febrile bone marrow transplant recipients with severe neutropenia.
Topics: Adolescent; Adult; Amikacin; Bacterial Infections; Bone Marrow Transplantation; Ceftazidime; Child; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Prospective Studies; Treatment Outcome; Vancomycin | 1999 |
Treatment of nosocomial postoperative pneumonia in cancer patients: a prospective randomized study.
Topics: Aged; Amikacin; Aztreonam; Chi-Square Distribution; Clindamycin; Cross Infection; Drug Therapy, Combination; Humans; Middle Aged; Neoplasms; Opportunistic Infections; Penicillanic Acid; Piperacillin; Pneumonia, Bacterial; Postoperative Complications; Prognosis; Prospective Studies; Tazobactam | 2001 |
Efficacy and tolerability of piperacillin/tazobactam versus ceftazidime in association with amikacin for treating nosocomial pneumonia in intensive care patients: a prospective randomized multicenter trial.
Topics: Aged; Amikacin; Ceftazidime; Cephalosporins; Critical Care; Cross Infection; Drug Therapy, Combination; Female; Hospital Mortality; Hospitals, Teaching; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Proportional Hazards Models; Prospective Studies; Spain; Survival Analysis; Treatment Outcome | 2001 |
[Efficacy of monotherapy by meropenem in ventilator-associated pneumonia].
Topics: Amikacin; Ceftazidime; Cross Infection; Drug Therapy, Combination; Female; Humans; Male; Meropenem; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Respiration, Artificial; Superinfection; Thienamycins | 2001 |
Prophylactic antibiotherapy in urological surgery.
Topics: Amikacin; Cefotaxime; Clinical Protocols; Cross Infection; Humans; Portugal; Postoperative Complications; Premedication; Risk Factors; Urinary Catheterization; Urology | 1992 |
Clinical and bacteriological efficacy, and practical aspects of amikacin given once daily for severe infections.
Topics: Adult; Aged; Amikacin; Bacterial Infections; Cefotaxime; Ceftazidime; Cross Infection; Drug Administration Schedule; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Male; Middle Aged; Ofloxacin; Piperacillin; Prospective Studies | 1991 |
Comparative efficacy of cefotetan and clindamycin plus amikacin as antimicrobial prophylaxis for major head and neck surgery.
Topics: Amikacin; Cefotetan; Clindamycin; Cross Infection; Female; Head and Neck Neoplasms; Humans; Male; Surgical Wound Infection | 1991 |
Prospective study of amikacin versus netilmicin in the treatment of severe infection in hospitalized patients.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Amikacin; Bacteria; Clinical Trials as Topic; Cross Infection; Ear; Female; Humans; Kidney; Male; Microbial Sensitivity Tests; Middle Aged; Netilmicin; Prospective Studies; Random Allocation; Superinfection | 1989 |
Therapeutic efficacy of the combination of aztreonam with cefotaxime in the treatment of severe nosocomial pneumonia. Comparative study against amikacin combined with cefotaxime.
Topics: Adult; Aged; Amikacin; Aztreonam; Cefotaxime; Clinical Trials as Topic; Cross Infection; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Male; Middle Aged; Pneumonia; Random Allocation | 1989 |
A comparative analysis of aztreonam + clindamycin versus tobramycin + clindamycin or amikacin + mezlocillin in the treatment of gram-negative lower respiratory tract infections.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Aztreonam; Bacterial Infections; Clindamycin; Clinical Trials as Topic; Cross Infection; Drug Therapy, Combination; Gram-Negative Bacteria; Humans; Male; Mezlocillin; Middle Aged; Pneumonia; Random Allocation; Tobramycin | 1989 |
[Prospective randomized controlled study of a ceftazidime and pefloxacin combination versus a ceftazidime and amikacin combination in the empirical treatment of pneumonia and nosocomial septicemia at intensive care units].
Topics: Amikacin; Ceftazidime; Cross Infection; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Male; Middle Aged; Multicenter Studies as Topic; Pefloxacin; Pneumonia; Prospective Studies; Random Allocation; Sepsis | 1989 |
Ceftazidime versus a combination of amikacin and ticarcillin in the treatment of severe infections.
Topics: Adult; Aged; Amikacin; Ceftazidime; Cross Infection; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Ticarcillin | 1988 |
[Controlled randomized prospective study of a ceftazidime-pefloxacin combination versus a ceftazidime-amikacin combination in the empirical treatment of nosocomial pneumonias and septicemias of resuscitation. Preliminary results].
Topics: Amikacin; Bacterial Infections; Ceftazidime; Clinical Trials as Topic; Cross Infection; Drug Therapy, Combination; Female; Humans; Male; Pefloxacin; Pneumonia; Prospective Studies; Random Allocation | 1988 |
Aminoglycoside resistance: a worldwide perspective.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Clinical Trials as Topic; Cross Infection; Drug Resistance, Microbial; Gentamicins; Humans; Kanamycin; Kidney; Klebsiella pneumoniae; Lactams; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin | 1986 |
Resistance surveillance programs and the incidence of gram-negative bacillary resistance to amikacin from 1967 to 1985.
Topics: Amikacin; Aminoglycosides; Clinical Trials as Topic; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae; Escherichia coli; Gentamicins; Gram-Negative Bacteria; Humans; Kanamycin; Klebsiella; Microbial Sensitivity Tests; Prospective Studies; Pseudomonas aeruginosa; Serratia; Tobramycin; United States | 1986 |
Azlocillin versus azlocillin plus amikacin in the treatment of severe infections in intensive care unit patients.
Topics: Adult; Aged; Amikacin; Azlocillin; Bacterial Infections; Critical Care; Cross Infection; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Random Allocation | 1987 |
Antibiotic resistance patterns during aminoglycoside restriction.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topic; Cross Infection; Drug Resistance, Microbial; Drug Utilization; Escherichia coli; Gentamicins; Gram-Negative Bacteria; Humans; Kanamycin; Pseudomonas aeruginosa; Time Factors | 1985 |
162 other study(ies) available for amikacin and Health Care Associated Infection
| Article | Year |
|---|---|
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Predictive Value of Tests; Proteus mirabilis; Risk Factors; Survival Analysis; Treatment Outcome | 2007 |
Spread in an Italian hospital of a clonal Acinetobacter baumannii strain producing the TEM-92 extended-spectrum beta-lactamase.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Humans; Italy; Microbial Sensitivity Tests | 2007 |
Enterobacteriaceae bloodstream infections: presence of integrons, risk factors, and outcome.
Topics: Bacteremia; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae Infections; Gene Transfer, Horizontal; Humans; Infectious Disease Transmission, Professional-to-Patient; Integrons; Microbial Sensitivity Tests; Nucleic Acid Amplification Techniques; Polymerase Chain Reaction; Prospective Studies; Risk Factors; Sequence Analysis, DNA; Treatment Outcome | 2007 |
Characterization of an integron carrying blaIMP-1 and a new aminoglycoside resistance gene, aac(6')-31, and its dissemination among genetically unrelated clinical isolates in a Brazilian hospital.
Topics: Acinetobacter; Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Base Sequence; Brazil; Codon, Terminator; Cross Infection; Drug Resistance, Multiple, Bacterial; Gene Transfer, Horizontal; Genes, Bacterial; Hospitals; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Open Reading Frames; Plasmids; Pseudomonas putida; Transcription, Genetic | 2007 |
Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.
Topics: Acinetobacter; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Blotting, Southern; Carbapenems; China; Chloramphenicol; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals; Humans; Imipenem; Integrons; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Rifampin; Sequence Analysis, DNA | 2007 |
Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Chromosomes, Bacterial; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Integrons; Molecular Epidemiology; Molecular Sequence Data; Mutation; Plasmids; Polymerase Chain Reaction; Porins; Pseudomonas aeruginosa; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Spain | 2007 |
Complex class 1 integrons with diverse variable regions, including aac(6')-Ib-cr, and a novel allele, qnrB10, associated with ISCR1 in clinical enterobacterial isolates from Argentina.
Topics: Alleles; Amino Acid Sequence; Argentina; Bacterial Proteins; Base Sequence; beta-Lactamases; Cross Infection; DNA Transposable Elements; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Analysis, DNA; Sequence Homology, Nucleic Acid | 2007 |
Metallo-beta-lactamase gene bla(IMP-15) in a class 1 integron, In95, from Pseudomonas aeruginosa clinical isolates from a hospital in Mexico.
Topics: Bacterial Proteins; beta-Lactamases; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Humans; Integrons; Mexico; Models, Genetic; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections | 2008 |
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Turkey | 2008 |
A plasmid-borne blaOXA-58 gene confers imipenem resistance to Acinetobacter baumannii isolates from a Lebanese hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Conjugation, Genetic; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Hospitals, University; Humans; Imipenem; Lebanon; Molecular Epidemiology; Molecular Sequence Data; Plasmids | 2008 |
Genetic basis of multidrug resistance in Acinetobacter baumannii clinical isolates at a tertiary medical center in Pennsylvania.
Topics: Academic Medical Centers; Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Base Sequence; beta-Lactamases; Cross Infection; DNA Primers; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Pennsylvania; Polymerase Chain Reaction | 2008 |
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Topics: Anti-Bacterial Agents; Base Sequence; beta-Lactamases; Colistin; Cross Infection; Humans; Molecular Sequence Data; Pseudomonas aeruginosa | 2009 |
Phenotypic and genotypic characterization of Enterobacteriaceae with decreased susceptibility to carbapenems: results from large hospital-based surveillance studies in China.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Genotype; Integrons; Microbial Sensitivity Tests; Phenotype; Population Surveillance; Porins; Reverse Transcriptase Polymerase Chain Reaction | 2010 |
Incidence and antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae with extended-spectrum beta-lactamases in community- and hospital-associated intra-abdominal infections in Europe: results of the 2008 Study for Monitoring Antimicrob
Topics: Abdomen; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2010 |
Antimicrobial resistance profiles and associated factors of Acinetobacter and Pseudomonas aeruginosa nosocomial infection among patients admitted at Dessie comprehensive specialized Hospital, North-East Ethiopia. A cross-sectional study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Child; Child, Preschool; Cross Infection; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Ethiopia; Female; Hospitals, Special; Humans; Infant; Infant, Newborn; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Patient Admission; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Treatment Outcome; Young Adult | 2021 |
Machine learning for identifying resistance features of
Topics: Amikacin; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Gentamicins; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Machine Learning; Microbial Sensitivity Tests; Polymorphism, Single Nucleotide; Tetracyclines | 2021 |
Antibiotic Abuse and Antimicrobial Resistance in Hospital Environment: A Retrospective Observational Comparative Study.
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Hospitals; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nitrofurantoin; Retrospective Studies; Staphylococcus aureus; Vancomycin | 2022 |
Antibiotic Guidelines for Critically Ill Patients in Nigeria.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Clavulanic Acid; Community-Acquired Infections; Critical Illness; Cross Infection; Fluconazole; Humans; Meropenem; Microbial Sensitivity Tests; Nigeria; Piperacillin, Tazobactam Drug Combination; Pneumonia; Prospective Studies; Urinary Tract Infections | 2023 |
Nosocomial outbreak linked to a flexible gastrointestinal endoscope contaminated with an amikacin-resistant ST17 clone of Pseudomonas aeruginosa.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Endoscopes, Gastrointestinal; Equipment Contamination; Female; Humans; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Spain | 2020 |
FDA's Limited Population Pathway for Antibacterial and Antifungal Drugs.
Topics: Administration, Inhalation; Amikacin; Anti-Bacterial Agents; Antifungal Agents; Cross Infection; Drug Approval; Drug Resistance, Microbial; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Humans; Liposomes; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Nitroimidazoles; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Sisomicin; United States; United States Food and Drug Administration | 2021 |
A change for the antibacterial treatment policy to decrease carbapenem consumption at a haematopoietic stem cell transplantation centre.
Topics: Amikacin; Anti-Bacterial Agents; Carbapenems; Cross Infection; Febrile Neutropenia; Guidelines as Topic; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Penicillanic Acid; Piperacillin; Retrospective Studies; Tazobactam; Teicoplanin; Tertiary Care Centers; Treatment Outcome; Turkey; Vancomycin | 2017 |
First report of cavitary pneumonia due to community-acquired Acinetobacter pittii, study of virulence and overview of pathogenesis and treatment.
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Animals; Caenorhabditis elegans; Community-Acquired Infections; Cross Infection; Female; France; Humans; Middle Aged; Multilocus Sequence Typing; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Virulence | 2017 |
Antibacterial Activity of Gold Nanoparticles Conjugated by Aminoglycosides Against
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Burns; Cross Infection; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gentamicins; Gold; Humans; Metal Nanoparticles; Microbial Sensitivity Tests; Patents as Topic; Wound Infection | 2018 |
Antimicrobial activity of ceftolozane-tazobactam against multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa clinical isolates from a Spanish hospital.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Spain; Tazobactam | 2019 |
Aminoglycoside Resistance Genes in Acinetobacter baumannii Clinical Isolates.
Topics: Acetyltransferases; Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Gentamicins; Humans; Microbial Sensitivity Tests; Nucleotidyltransferases; Phosphotransferases | 2019 |
The treatment of nosocomial meningitis and brain abscess by carbapenem-resistant
Topics: Adult; Amikacin; Anti-Bacterial Agents; Brain Abscess; Carbapenem-Resistant Enterobacteriaceae; Cross Infection; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Meningitis; Meropenem; Microbial Sensitivity Tests; Pneumonia; Sulfamethoxazole | 2023 |
Sccmec type II gene is common among clinical isolates of methicillin-resistant Staphylococcus aureus in Jakarta, Indonesia.
Topics: Acetamides; Amikacin; Clindamycin; Community-Acquired Infections; Cross Infection; DNA Primers; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Humans; Indonesia; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Plasmids; Polymerase Chain Reaction; Species Specificity; Teicoplanin; Tigecycline; Time Factors; Vancomycin | 2013 |
In vitro activity of doripenem alone and in multi-agent combinations against extensively drug-resistant Acinetobacter baumannii and Klebsiella pneumoniae.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymyxin B; Rifampin | 2013 |
Risk factors and outcomes of infections caused by extremely drug-resistant gram-negative bacilli in patients hospitalized in intensive care units.
Topics: Acinetobacter Infections; Adolescent; Age Factors; Aged; Amikacin; Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacterial Infections; Hospital Mortality; Humans; Immunocompromised Host; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Liver Diseases; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Time Factors | 2014 |
Interactions of amikacin with the RNA model of the ribosomal A-site: computational, spectroscopic and calorimetric studies.
Topics: Amikacin; Binding Sites; Calorimetry, Differential Scanning; Circular Dichroism; Computer Simulation; Cross Infection; Humans; Nucleic Acid Conformation; Oligonucleotides; Ribosome Subunits, Small; RNA; Spectrum Analysis; Thermodynamics | 2014 |
Can Plazomicin Alone or in Combination Be a Therapeutic Option against Carbapenem-Resistant Acinetobacter baumannii?
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; Cross Infection; Drug Synergism; Drug Therapy, Combination; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Sisomicin; Thienamycins | 2015 |
In vitro activity of aminoglycosides against clinical isolates of Acinetobacter baumannii complex and other nonfermentative Gram-negative bacilli causing healthcare-associated bloodstream infections in Taiwan.
Topics: Acinetobacter baumannii; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Burkholderia cepacia; Cross Infection; Drug Resistance, Bacterial; Gentamicins; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Stenotrophomonas maltophilia; Tobramycin | 2016 |
Acinetobacter baumannii in Southern Croatia: clonal lineages, biofilm formation, and resistance patterns.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Biofilms; Carbapenems; Croatia; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Humans; Intensive Care Units; Microbial Sensitivity Tests; Monte Carlo Method; Respiratory System; Respiratory Tract Infections; Sulbactam; Urine; Wounds and Injuries | 2015 |
Outbreak of drug-resistant Acinetobacter baumannii ST219 caused by oral care using tap water from contaminated hand hygiene sinks as a reservoir.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Cross Infection; Disease Outbreaks; Disease Transmission, Infectious; Drug Resistance, Bacterial; Emergency Service, Hospital; Genotype; Hand Hygiene; Hospitals, University; Humans; Infection Control; Intensive Care Units; Japan; Water Microbiology | 2015 |
Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoxitin; China; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Gene Expression; Humans; Imipenem; Intraabdominal Infections; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam | 2016 |
Epidemiology and Antimicrobial Susceptibility of Gram-Negative Pathogens Causing Intra-abdominal Infections in Pediatric Patients in Europe-SMART 2011-2014.
Topics: Adolescent; Amikacin; Appendicitis; Child; Child, Preschool; Community-Acquired Infections; Cross Infection; Cross-Sectional Studies; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Europe; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Infant; Male; Microbial Sensitivity Tests | 2017 |
In vitro potency of amikacin and comparators against E. coli, K. pneumoniae and P. aeruginosa respiratory and blood isolates.
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; beta-Lactams; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Middle Aged; Models, Statistical; Pseudomonas aeruginosa; Pseudomonas Infections; United States | 2016 |
Antimicrobial-resistant Pseudomonas aeruginosa and Acinetobacter baumannii From Patients With Hospital-acquired or Ventilator-associated Pneumonia in Vietnam.
Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Cross Infection; Doripenem; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gentamicins; Humans; Longitudinal Studies; Microbial Sensitivity Tests; Minocycline; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Tigecycline; Vietnam | 2016 |
Prospective study analyzing risk factors and characteristics of healthcare-associated infections in a Urology ward.
Topics: Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Catheters, Indwelling; Cross Infection; Cystectomy; Drug Resistance, Microbial; Enterococcus; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Hospital Units; Humans; Immunosuppression Therapy; Incidence; Klebsiella; Klebsiella Infections; Male; Middle Aged; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Surgical Wound Infection; Urinary Catheters; Urinary Tract Infections; Urology; Vancomycin | 2017 |
Epidemiology and susceptibility of pathogens from SMART 2011-12 Turkey: evaluation of hospital-acquired versus community-acquired urinary tract infections and ICU- versus non-ICU-associated intra-abdominal infections.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefoxitin; Community-Acquired Infections; Cross Infection; Enterobacteriaceae; Ertapenem; Escherichia coli; Humans; Imipenem; Intensive Care Units; Intraabdominal Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Turkey; Urinary Tract Infections | 2017 |
Antimicrobial therapy and control of multidrug-resistant Pseudomonas aeruginosa bacteremia in a teaching hospital in Taiwan.
Topics: Aged; Aged, 80 and over; Amikacin; Anti-Infective Agents; Bacteremia; Ceftazidime; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Synergism; Electrophoresis, Gel, Pulsed-Field; Female; Hospitals, Teaching; Humans; Infection Control; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Sulbactam; Taiwan | 2008 |
Antibiotic susceptibility patterns of Pseudomonas aeruginosa to available antipseudomonal drugs in Ibadan, Nigeria.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Ciprofloxacin; Cross Infection; Drug Resistance, Multiple, Bacterial; Hospitals, University; Humans; Microbial Sensitivity Tests; Nigeria; Pseudomonas aeruginosa; Pseudomonas Infections | 2008 |
Activity of amikacin, ertapenem, ciprofloxacin and levofloxacin alone and in combination against resistant nosocomial pathogens by time-kill.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Cross Infection; Drug Synergism; Drug Therapy, Combination; Ertapenem; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin | 2008 |
Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia.
Topics: Aerosols; Amikacin; Anti-Bacterial Agents; Cross Infection; Gram-Negative Bacterial Infections; Humans; Intubation; Lung; Respiration, Artificial | 2009 |
Outbreak of vim-1-carbapenemase-producing Enterobacter cloacae in a pediatric intensive care unit.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Child; Cross Infection; Disease Outbreaks; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Humans; Infant; Integrons; Intensive Care Units, Pediatric; Male; Plasmids; Trimethoprim, Sulfamethoxazole Drug Combination | 2010 |
Asymptomatic catheter related Rhizobium radiobacter infection in a haploidentical hemapoetic stem cell recipient.
Topics: Agrobacterium tumefaciens; Amikacin; Anti-Bacterial Agents; Blood; Catheter-Related Infections; Catheterization, Central Venous; Catheters; Cefepime; Cephalosporins; Cross Infection; Female; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Infant; Severe Combined Immunodeficiency; Stem Cell Transplantation | 2010 |
[Epidemiology and drug susceptibility of Pseudomonas aeruginosa strains isolated in the Chugoku region of Japan. Infection Forum in the Chugoku Region].
Topics: Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Imipenem; Japan; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum; Urine | 2011 |
Further increases in carbapenem-, amikacin-, and fluoroquinolone-resistant isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR study 2009.
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Republic of Korea | 2011 |
[Neonatal infection with Stenotrophomonas maltophilia (2 case studies)].
Topics: Amikacin; Anti-Bacterial Agents; Brain Abscess; Chloramphenicol; Ciprofloxacin; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Echoencephalography; Empyema, Subdural; Fatal Outcome; Female; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Male; Meningitis, Bacterial; Microbial Sensitivity Tests; Pneumonia, Bacterial; Sepsis; Stenotrophomonas maltophilia; Thiamphenicol; Tomography, X-Ray Computed | 2012 |
Bacteremia caused by Acinetobacter junii at a medical center in Taiwan, 2000-2010.
Topics: Acinetobacter; Acinetobacter Infections; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; Carbapenems; Catheter-Related Infections; Central Venous Catheters; Colony Count, Microbial; Cross Infection; Drug Resistance, Bacterial; Female; Hospital Mortality; Humans; Incidence; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; RNA, Ribosomal, 16S; Sequence Analysis, RNA; Taiwan; Tertiary Care Centers; Tigecycline | 2012 |
[Occurrence of alert pathogens in hospital environment Part II. Multidrug-resistant non-fermenting bacilli].
Topics: Acinetobacter baumannii; Amikacin; Anesthesia Department, Hospital; Blood; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Environmental Monitoring; Epidemiological Monitoring; Humans; Incidence; Intensive Care Units; Microbial Sensitivity Tests; Poland; Pseudomonas aeruginosa; Respiratory System; Species Specificity; Urine; Wounds and Injuries | 2012 |
[The impact of antibiotic use on hospital-acquired pneumonia: data of etiology tests].
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Bronchoalveolar Lavage Fluid; Ceftazidime; Cefuroxime; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fusidic Acid; Gentamicins; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Methicillin; Microbial Sensitivity Tests; Middle Aged; Penicillins; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Staphylococcus aureus; Sulbactam; Vancomycin Resistance | 2003 |
[Nosocomial infections caused by Acinetobacter: experience in a neonatal care unit in Casablanca].
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Infant, Newborn; Intensive Care Units, Neonatal; Morocco; Retrospective Studies | 2003 |
Commentary: once-daily aminoglycoside dosing: where are we now?
Topics: Amikacin; Aminoglycosides; Cross Infection; Drug Administration Schedule; Drug Monitoring; Humans; Intensive Care Units | 2003 |
Evaluation of an amikacin loading dose for nosocomial infections in very low birthweight infants.
Topics: Amikacin; Anti-Bacterial Agents; Cross Infection; Female; Fluorescence Polarization Immunoassay; Gestational Age; Humans; Infant, Newborn; Infant, Very Low Birth Weight; Male | 2004 |
Antimicrobial susceptibility patterns in Pseudomonas aeruginosa: data from a multicenter Intensive Care Unit Surveillance Study (ISS) in the United States.
Topics: Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Humans; Intensive Care Units; Microbial Sensitivity Tests; Population Surveillance; Pseudomonas aeruginosa; Pseudomonas Infections; United States | 2004 |
[Resistance to gentamicin, amikacin and ciprofloxacin among nosocomial isolates of klebsiella pneumoniae subspecie pneumoniae producing extended spectrum beta-lactamases].
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Gentamicins; Humans; Klebsiella pneumoniae | 2004 |
Evaluation on the use of beta-lactamase and aminoglycoside modifying enzyme gene sequences as markers for the early detection of antibiotic resistance profile of Pseudomonas aeruginosa.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Biomarkers; Biotin; Blotting, Southern; Cross Infection; DNA; DNA Primers; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Electrophoresis, Agar Gel; Gentamicins; Humans; Microbial Sensitivity Tests; Nucleic Acid Hybridization; Penicillins; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections; Sensitivity and Specificity; Sequence Analysis, DNA; Streptomycin; Tobramycin | 2004 |
Postantibiotic effect of antimicrobial combinations on multidrug-resistant Pseudomonas aeruginosa.
Topics: Amikacin; Ceftazidime; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Sensitivity and Specificity | 2005 |
Report of an uncommon cluster of septic arthritis of the hip in premature newborns: three cases in a period of 3 months.
Topics: Amikacin; Anti-Bacterial Agents; Arthritis, Infectious; Cefuroxime; Cross Infection; Disease Outbreaks; Diseases in Twins; Hip Joint; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Switzerland; Ultrasonography | 2005 |
Pan-drug-resistant Pseudomonas aeruginosa causing nosocomial infection at a university hospital in Taiwan.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Child; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Synergism; Female; Hospitals, University; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Taiwan | 2005 |
Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.
Topics: Amikacin; Anti-Bacterial Agents; Critical Illness; Cross Infection; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Hospitals, University; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Phylogeny; Pseudomonas aeruginosa; Pseudomonas Infections; Turkey | 2006 |
Bacterial isolates from mechanically ventilated patients with nosocomial pneumonia within intensive care unit of a tertiary care center.
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Cross Infection; Humans; Intensive Care Units; Pneumonia, Bacterial; Respiration, Artificial | 2005 |
Validation of criteria for nosocomial use of amikacin in Brazil with the Delphi technique.
Topics: Amikacin; Anti-Bacterial Agents; Brazil; Cross Infection; Delphi Technique; Drug Utilization; Humans; Societies, Medical | 2006 |
[Antibmicrobial susceptibility of Serratia marcescens isolated from hospitalized patients in 2003 - 2005].
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Ciprofloxacin; Cross Infection; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Gentamicins; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Poland; Serratia marcescens; Thienamycins | 2007 |
Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved?
Topics: Algorithms; Amikacin; Anti-Bacterial Agents; beta-Lactams; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Intensive Care Units; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors | 2007 |
[Intrathecal use of amikacin and colistin].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Amikacin; Brain Ischemia; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fatal Outcome; Humans; Hydrocephalus; Injections, Spinal; Male; Meningitis, Bacterial; Pseudomonas Infections; Shock, Septic; Surgical Wound Infection; Ventriculostomy | 2008 |
New plasmid-mediated aminoglycoside adenylyltransferase of broad substrate range that adenylylates amikacin.
Topics: Amikacin; Aminoglycosides; Conjugation, Genetic; Cross Infection; Gentamicins; Humans; Hydrogen-Ion Concentration; Kanamycin; Klebsiella pneumoniae; Molecular Weight; Nucleotidyltransferases; Plasmids; Substrate Specificity | 1981 |
Infection with netilmicin resistant Serratia marcescens in a special care baby unit.
Topics: Acetyltransferases; Amikacin; Cefotaxime; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterobacteriaceae Infections; Gentamicins; Humans; Infant, Newborn; Netilmicin; Nurseries, Hospital; Serratia marcescens; Tobramycin | 1983 |
Replacement of gentamicin by amikacin as a means of decreasing gentamicin resistance of gram-negative rods in a neonatal intensive care unit.
Topics: Amikacin; Bacterial Infections; Cross Infection; Drug Resistance, Microbial; Gentamicins; Humans; Infant, Newborn; Infant, Premature, Diseases; Intensive Care Units, Neonatal; Kanamycin | 1983 |
[Comparative study and time changes in the resistance to gentamycin, tobramycin, sisomicin and amikacin of Gram-negative nosocomial bacterial strains isolated from the urinary tract, in relation to the annual use of the aminoglycosides tested].
Topics: Amikacin; Cross Infection; Drug Resistance, Microbial; Gentamicins; Gram-Negative Bacteria; Humans; Kanamycin; Sisomicin; Tobramycin; Urinary Tract Infections | 1983 |
Five-year surveillance of aminoglycoside usage in a university hospital.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Drug Utilization; Enterobacteriaceae Infections; Gentamicins; Hospitals, University; Humans; Middle Aged; New York; Prospective Studies; Pseudomonas Infections | 1984 |
A cluster of cases of Mycobacterium chelonei keratitis associated with outpatient office procedures.
Topics: Aged; Ambulatory Care Facilities; Amikacin; Cross Infection; Erythromycin; Female; Humans; Keratitis; Male; Mycobacterium Infections | 1984 |
Endemic aminoglycoside resistance in gram-negative bacilli: epidemiology and mechanisms.
Topics: Amikacin; Aminoglycosides; Chicago; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Gentamicins; Gram-Negative Aerobic Bacteria; Humans; Klebsiella; Microbial Sensitivity Tests; Netilmicin; Pseudomonadaceae; Pseudomonas aeruginosa; Tobramycin; Urine | 1980 |
A long-term study of gentamicin-resistant Pseudomonas aeruginosa in a general hospital.
Topics: Amikacin; Cross Infection; Drug Resistance, Microbial; Gentamicins; Hospitals, General; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 1981 |
Outbreak of amikacin-resistant Enterobacteriaceae in an intensive care nursery.
Topics: Amikacin; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae Infections; Female; Humans; Infant, Newborn; Infant, Newborn, Diseases; Intensive Care Units; Kanamycin; Klebsiella Infections; Klebsiella pneumoniae; Male; Netilmicin; Nurseries, Hospital; Serratia marcescens; Sisomicin | 1980 |
Distribution of genes for trimethoprim and gentamicin resistance in bacteria and their plasmids in a general hospital.
Topics: Amikacin; Chromosome Deletion; Cross Infection; Drug Resistance, Microbial; Escherichia coli; Extrachromosomal Inheritance; Gentamicins; Gram-Negative Aerobic Bacteria; Humans; R Factors; Tobramycin; Trimethoprim | 1980 |
The effect of chronologic age on the serum concentrations of amikacin in sick term and premature infants.
Topics: Age Factors; Amikacin; Bacterial Infections; Cross Infection; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature, Diseases; Injections, Intravenous; Kanamycin; Microbial Sensitivity Tests | 1981 |
Resistance to aminoglycoside antibiotics of gram-negative bacilli isolated in Canadian hospitals.
Topics: Amikacin; Anti-Bacterial Agents; Canada; Cross Infection; Drug Resistance, Microbial; Gentamicins; Gram-Negative Aerobic Bacteria; Hospitals, Teaching; Humans; Kanamycin; Tobramycin | 1981 |
Epidemiological studies of aminoglycoside resistance in the U.S.A.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacteria; Cross Infection; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; United States | 1981 |
An epidemic oc gentamicin/cloxacillin resistant staphylococcal infection in a neonatal unit.
Topics: Amikacin; Clindamycin; Cloxacillin; Cross Infection; Female; Gentamicins; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Kanamycin; Male; Pneumonia, Staphylococcal; R Factors; Staphylococcal Infections; Staphylococcus aureus | 1981 |
Prevalence of gentamicin- and amikacin-resistant bacteria in sink drains.
Topics: Amikacin; Bacteria; Bacterial Infections; Cross Infection; Disease Reservoirs; Drainage, Sanitary; Drug Resistance, Microbial; Gentamicins; Humans; Kanamycin; Species Specificity; Water Microbiology | 1980 |
Determination of plasma concentrations of amikacin in patients of an intensive care unit.
Topics: Adult; Amikacin; Aminoglycosides; Critical Illness; Cross Infection; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Intensive Care Units; Male; Middle Aged | 1995 |
An 8-year study of resistance to amikacin in gram-negative bacilli isolates from patients with nosocomial infection at one hospital in Argentina.
Topics: Acinetobacter; Amikacin; Argentina; Cross Infection; DNA, Bacterial; Drug Resistance, Microbial; Enterobacteriaceae; Gentamicins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; R Factors | 1995 |
[Bacterial resistance in clinical isolates of Klebsiella pneumoniae].
Topics: Acetyltransferases; Amikacin; Ampicillin Resistance; Cefotaxime; Cross Infection; Drug Resistance, Microbial; Humans; Klebsiella pneumoniae | 1995 |
Antibiotic-resistant Acinetobacter meningitis in neurosurgical patients.
Topics: Acinetobacter Infections; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; Bacteriological Techniques; Brain Diseases; Brain Neoplasms; Cross Infection; Drug Resistance, Microbial; Female; Humans; Imipenem; Male; Meningitis, Bacterial; Middle Aged; Postoperative Complications; Recurrence; Risk Factors; Surgical Wound Infection | 1994 |
Clinical and bacteriological survey after change in aminoglycoside treatment to control an epidemic of Enterobacter cloacae.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Cohort Studies; Cross Infection; Disease Outbreaks; Drug Therapy, Combination; Enterobacter cloacae; Enterobacteriaceae Infections; France; Gentamicins; Humans; Infant, Newborn; Intensive Care Units, Neonatal | 1994 |
In vitro stepwise selection of resistance to quinolones, beta-lactams and amikacin in nosocomial gram-negative bacilli.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Evaluation Studies as Topic; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Infection Control; Risk Factors | 1994 |
Serotypes and extended spectrum beta-lactam resistance in aminoglycoside resistant Pseudomonas aeruginosa isolates from two Belgian general hospitals: a seven year study.
Topics: Amikacin; Anti-Bacterial Agents; Belgium; beta-Lactams; Cross Infection; Drug Resistance, Microbial; Gentamicins; Hospitals; Humans; Pseudomonas aeruginosa; Serotyping | 1993 |
Neonatal suppurative parotitis: a vanishing disease?
Topics: Amikacin; Cross Infection; Drainage; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Parotitis; Suppuration; Vancomycin | 1993 |
[Molecular characterization of the transferable resistance to amikacin in Enterobacteriaceae strains isolated from hospital infections].
Topics: Amikacin; Conjugation, Genetic; Cross Infection; Drug Resistance, Microbial; Electrophoresis, Agar Gel; Enterobacteriaceae; Humans; In Vitro Techniques; Plasmids | 1993 |
Molecular epidemiologic study of an outbreak of Salmonella typhimurium infection at a newborn nursery.
Topics: Amikacin; China; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Female; Humans; Infant, Newborn; Nurseries, Hospital; Pregnancy; Salmonella Infections; Salmonella typhimurium | 1993 |
Gentamicin-resistant Enterobacteriaceae in a neonatal intensive care unit.
Topics: Amikacin; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Gentamicins; Humans; Hygiene; Infant, Newborn; Intensive Care Units, Neonatal | 1993 |
Modeling and simulating the evolution of resistance against antibiotics.
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Computer Simulation; Cross Infection; Disease Susceptibility; Drug Resistance, Microbial; Ecology; Humans; Klebsiella Infections; Klebsiella pneumoniae; Models, Biological; Mutation; Plasmids; Transformation, Bacterial | 1993 |
Activity of selected beta-lactams, ciprofloxacin, and amikacin against different Acinetobacter baumannii biotypes from Chilean hospitals.
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactams; Chile; Ciprofloxacin; Cross Infection; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Multicenter Studies as Topic | 1997 |
Gram-negative bacilli isolated from patients in intensive care unit: prevalence and antibiotic susceptibility.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Blood; Carbapenems; Cephalosporins; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Imipenem; Intensive Care Units; Microbial Sensitivity Tests; Respiratory Tract Infections; Saudi Arabia; Urinary Tract Infections; Wounds and Injuries | 1997 |
[Sensitivity of Pseudomonas aeruginosa to amikacin and to isepamicin in surgery and in intensive care].
Topics: Amikacin; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Gentamicins; Humans; Intensive Care Units; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Surgery Department, Hospital | 1997 |
[Importance of the association ticarcillin-clavulanic acid-amikacin in the treatment of severe urinary infections after major urodigestive surgery. Report of 59 cases].
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Clavulanic Acid; Cross Infection; Digestive System Surgical Procedures; Drug Therapy, Combination; Humans; Middle Aged; Postoperative Care; Ticarcillin; Urinary Tract Infections; Urologic Surgical Procedures | 1998 |
Outpatient management of acute promyelocytic leukemia after consolidation chemotherapy.
Topics: Adult; Aged; Ambulatory Care; Amikacin; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Ceftriaxone; Cerebral Hemorrhage; Cross Infection; Drug Therapy, Combination; Emergency Service, Hospital; Female; Fever; Hospitalization; Humans; Idarubicin; Incidence; Length of Stay; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neutropenia; Remission Induction; Tretinoin | 1999 |
Outbreak of extended spectrum beta lactamase producing Klebsiella pneumoniae in a neonatal unit.
Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cross Infection; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Klebsiella Infections; Klebsiella pneumoniae; Male | 1999 |
Nosocomial outbreak of gentamicin-resistant Klebsiella pneumoniae in a neonatal intensive care unit controlled by a change in antibiotic policy.
Topics: Amikacin; Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Gentamicins; Hospitals, University; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Klebsiella Infections; Klebsiella pneumoniae; Netherlands; Organizational Policy; Polymorphism, Restriction Fragment Length; Risk Factors | 1999 |
Prevalent nosocomial gram negative aerobic bacilli and their antimicrobial susceptibility pattern in intensive care unit.
Topics: Amikacin; Anti-Bacterial Agents; Cross Infection; Gram-Negative Bacterial Infections; Humans; Imipenem; Infant, Newborn; Intensive Care Units; Microbial Sensitivity Tests; Prospective Studies; Thienamycins | 1999 |
Systemic antibiotics fail to clear multidrug-resistant Klebsiella from a pediatric ICU.
Topics: Amikacin; beta-Lactamase Inhibitors; Cohort Studies; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Infant; Intensive Care Units, Pediatric; Klebsiella; Klebsiella Infections; Male; Penicillanic Acid; Piperacillin; Prospective Studies; Tazobactam | 2001 |
Nosocomial outbreak due to a multiresistant strain of Pseudomonas aeruginosa P12: efficacy of cefepime-amikacin therapy and analysis of beta-lactam resistance.
Topics: Adult; Amikacin; Bacterial Outer Membrane Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections; Ribotyping | 2001 |
Antibiotic susceptibility and phage typing of methicillin-resistant and -sensitive Staphylococcus aureus clinical isolates at three periods during 1991-1997.
Topics: Amikacin; Anti-Bacterial Agents; Bacteriophage Typing; Cross Infection; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Penicillins; Prevalence; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2001 |
Mycobacterium fortuitum wound infection following laparoscopy.
Topics: Amikacin; Ciprofloxacin; Cross Infection; Humans; Laparoscopy; Mycobacterium fortuitum; Mycobacterium Infections; Surgical Wound Infection | 2001 |
Departmental consumption of antibiotic drugs and subsequent resistance: a quantitative link.
Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, University; Humans; Internal Medicine; Logistic Models | 2001 |
[Nosocomial catheter-related sepsis secondary to central venous catheters].
Topics: Amikacin; Anti-Bacterial Agents; Catheterization, Central Venous; Cross Infection; Drug Resistance, Microbial; Female; Gram-Negative Aerobic Bacteria; Gram-Positive Cocci; Humans; Male; Middle Aged; Retrospective Studies; Sepsis; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin | 1999 |
Gentamicin-resistant Pseudomonas aeruginosa and Serratia marcescens in a general hospital.
Topics: Amikacin; Aminoglycosides; California; Carbenicillin; Cross Infection; Enterobacteriaceae Infections; Gentamicins; Hospitals, General; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Penicillin Resistance; Pseudomonas aeruginosa; Pseudomonas Infections; Serratia marcescens; Sisomicin; Tobramycin | 1976 |
Amikacin therapy of patients with multiply antibiotic-resistant Serratia marcescens infections: development of increasing resistance during therapy.
Topics: Adult; Aged; Amikacin; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterobacteriaceae Infections; Female; Humans; Kanamycin; Male; Middle Aged; Serratia marcescens; Urinary Tract Infections | 1977 |
Experience with amikacin and colistin in an outbreak of infection by resistant Klebsiella aerogenes.
Topics: Aged; Amikacin; Colistin; Cross Infection; Disease Outbreaks; Drug Administration Schedule; Drug Resistance, Microbial; Female; Humans; Injections, Intramuscular; Injections, Intravenous; Kanamycin; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Urinary Tract Infections | 1977 |
Amikacin therapy of gram-negative bacteremia and meningitis. Treatment in diseases due to multiple resistant bacilli.
Topics: Adolescent; Adult; Aged; Amikacin; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae Infections; Escherichia coli Infections; Humans; Kanamycin; Klebsiella Infections; Meningitis; Proteus Infections; Sepsis; Serratia marcescens | 1978 |
Simultaneous nosocomial outbreaks caused by multiply resistant Klebsiella pneumoniae types 2 and 30.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Gentamicins; Humans; Klebsiella Infections; Klebsiella pneumoniae | 1978 |
[Sero-types and drug sensitivity of Serratia marcescens isolated from pathological specimens, with special reference to hospital infections. II. (author's transl)].
Topics: Amikacin; Cross Infection; Gentamicins; Humans; Microbial Sensitivity Tests; Serotyping; Serratia marcescens; Tobramycin | 1979 |
Gentamicin-resistant bacillary infection. Clinical features and amikacin therapy.
Topics: Adult; Aged; Amikacin; Bacterial Infections; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae Infections; Female; Gentamicins; Humans; In Vitro Techniques; Infant; Kanamycin; Male; Middle Aged; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Serratia marcescens; Urinary Tract Infections | 1978 |
The comparative efficacy and safety of aminoglycoside antibiotics.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Gentamicins; Hospitals; South Africa; Tobramycin; Utilization Review | 1979 |
[Treatment of hospital-acquired urinary infections with amikacin (author's transl)].
Topics: Amikacin; Cross Infection; Drug Evaluation; Drug Resistance, Microbial; Female; Hearing Disorders; Humans; Kanamycin; Male; Middle Aged; Urinary Tract Infections | 1979 |
[Enterobacteria isolated in hospitals. Comparison of the bacteriostatic and bactericidal activity of amikacin, gentamicin and tobramycin].
Topics: Amikacin; Anti-Bacterial Agents; Cross Infection; Enterobacteriaceae; Gentamicins; Humans; Kanamycin; Microbial Sensitivity Tests; Species Specificity; Tobramycin | 1979 |
[Phenotypes of resistance to aminosides and sensitivity of amikacin in hospitals].
Topics: Amikacin; Aminoglycosides; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae; Gram-Negative Anaerobic Bacteria; Humans; Kanamycin; Phenotype; Species Specificity; Staphylococcus aureus | 1979 |
[Clinical and pharmacokinetic study of amikacin in pediatrics].
Topics: Amikacin; Child; Cross Infection; Humans; Kanamycin; Microbial Sensitivity Tests; Pediatrics | 1979 |
[Amikacin, in association, in severe infections due to Gram-negative bacteria].
Topics: Adult; Aged; Amikacin; Cross Infection; Drug Tolerance; Female; Humans; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Postoperative Complications | 1979 |
In vitro sensitivity of hospital strains of Serratia marcescens to chemotherapeutic agents.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Carbenicillin; Chloramphenicol; Cross Infection; Erythromycin; Gentamicins; Humans; Kanamycin; Microbial Sensitivity Tests; Nalidixic Acid; Novobiocin; Rifampin; Serratia marcescens; Sputum; Streptomycin; Sulfamethoxazole; Tetracycline; Trimethoprim; Urine; Wound Infection | 1976 |
Use of Amikacin in a hospital for children: microbiological and clinical studies.
Topics: Amikacin; Aminoglycosides; Bacterial Infections; Child; Child, Preschool; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature, Diseases; Kanamycin; Kidney Failure, Chronic; Male; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Urinary Tract Infections | 1976 |
Nosocomial bloodstream infections caused by gentamicin-resistant gram-negative bacilli.
Topics: Adult; Aged; Amikacin; Cross Infection; Drug Resistance, Microbial; Female; Gentamicins; Gram-Negative Aerobic Bacteria; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Sepsis | 1977 |
Treatment of hospita-acquired infections with amikacin.
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Cross Infection; Female; Humans; Kanamycin; Male; Middle Aged; Proteus; Proteus Infections; Urinary Tract Infections | 1977 |
Amikacin treatment of pulmonary infections involving gentamicin-resistant gram-negative bacilli.
Topics: Amikacin; Bacteria; Bacterial Infections; Cross Infection; Drug Resistance, Microbial; Gentamicins; Humans; Kanamycin; Lung Diseases | 1977 |
An overview of pediatric experience with amikacin.
Topics: Amikacin; Bacterial Infections; Child; Cross Infection; Enterobacteriaceae Infections; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Kanamycin | 1977 |
[Pharmacokinetics and clinical experiences with a new aminoglycoside antibioticum: amikacin].
Topics: Adult; Amikacin; Bacterial Infections; Cross Infection; Drug Evaluation; Female; Humans; Kanamycin; Male; Middle Aged | 1976 |
Multidrug-resistant Proteus rettgeri: an emerging problem.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Cephalothin; Cross Infection; Gentamicins; Humans; Kanamycin; Penicillin Resistance; Proteus; Proteus Infections; R Factors; Urinary Tract Infections | 1976 |
Multiresistant Klebsiella pneumoniae in a neonatal nursery: the importance of maintenance of infection control policies and procedures in the prevention of outbreaks.
Topics: Amikacin; Carrier State; Cefotaxime; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Hospitals, Teaching; Humans; Infant; Infant, Newborn; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Methicillin Resistance; Microbial Sensitivity Tests; Nurseries, Hospital; South Africa | 1992 |
[Diffusion of amikacin into the sinuses in patients with nosocomial sinusitis. Administration of a single dose per day].
Topics: Adult; Aged; Amikacin; Bacteroides Infections; Cross Infection; Diffusion; Dose-Response Relationship, Drug; Drug Therapy, Combination; Escherichia coli Infections; Female; Humans; Injections, Intravenous; Male; Middle Aged; Paranasal Sinuses; Sinusitis; Streptococcal Infections | 1992 |
[Evolution of the bacteria responsible for surgical infection. n 8-year study in our department].
Topics: Amikacin; Ampicillin Resistance; Bacteria; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Humans; Imipenem; Penicillin Resistance; Surgical Procedures, Operative; Time Factors | 1992 |
[In vitro activity of various antibiotic agents against gram-negative nosocomial bacteremia pathogens].
Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Cross Infection; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Ofloxacin | 1992 |
Comparative activity of meropenem (SM-7338) against major respiratory pathogens and amikacin-resistant nosocomial isolates.
Topics: Amikacin; Bacteria; Cross Infection; Drug Resistance, Microbial; Humans; Meropenem; Microbial Sensitivity Tests; Respiratory Tract Infections; Thienamycins | 1992 |
Nosocomial spread of an amikacin resistance gene on both a mobilized, nonconjugative plasmid and a conjugative plasmid.
Topics: Alleles; Amikacin; Conjugation, Genetic; Cross Infection; DNA Transposable Elements; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella pneumoniae; Operon; Plasmids | 1991 |
[Intratracheal bolus of amikacin. An efficient adjuvant treatment of bronchial superinfection in major digestive surgery].
Topics: Administration, Inhalation; Amikacin; Cross Infection; Digestive System Surgical Procedures; Humans; Respiratory Tract Infections | 1991 |
Nosocomial outbreaks due to amikacin-resistant tobramycin-sensitive Acinetobacter species: correlation with amikacin usage.
Topics: Acinetobacter Infections; Amikacin; Bacteriophage Typing; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; France; Hospitals, Teaching; Humans; Microbial Sensitivity Tests; Retrospective Studies; Serotyping; Tobramycin | 1990 |
Comparative in vitro activity of the new quinolone sparfloxacin (CI-978, AT-4140) against nosocomial gram-negative bloodstream isolates.
Topics: Amikacin; Anti-Infective Agents; Cephalosporins; Ciprofloxacin; Cross Infection; Enterobacteriaceae; Fluoroquinolones; Gram-Negative Bacteria; Humans; Imipenem; Pseudomonas aeruginosa; Sepsis; Tobramycin | 1990 |
[Drug resistance and floral distribution of Pseudomonas aeruginosa].
Topics: Amikacin; Burns; Ceftazidime; Cross Infection; Drug Resistance, Microbial; Female; Humans; Middle Aged; Norfloxacin; Pseudomonas aeruginosa; Serotyping | 1990 |
Hospital-acquired neonatal bacterial meningitis: the impacts of cefotaxime usage on mortality and of amikacin usage on incidence.
Topics: Amikacin; Cefotaxime; Cross Infection; Humans; Infant, Newborn; Meningitis; South Africa | 1989 |
Two possibly related cases of Mycobacterium fortuitum peritonitis associated with continuous ambulatory peritoneal dialysis.
Topics: Adult; Amikacin; Cross Infection; Doxycycline; Drug Therapy, Combination; Humans; Male; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1989 |
Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae.
Topics: Amikacin; beta-Lactamases; Cefotaxime; Cephalosporins; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterobacteriaceae; Escherichia coli; Humans; Klebsiella Infections; Klebsiella pneumoniae; Paris; Recurrence; Urinary Tract Infections | 1987 |
Bactericidal activity of ciprofloxacin against amikacin- and cefotaxime-resistant gram-negative bacilli and methicillin-resistant staphylococci.
Topics: Amikacin; Cefotaxime; Ciprofloxacin; Cross Infection; Gram-Negative Bacteria; Humans; Kanamycin; Methicillin; Penicillin Resistance; Quinolines; Staphylococcus | 1986 |
Control of emergence of multi-resistant gram-negative bacilli by exclusive use of amikacin.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae; Gentamicins; Gram-Negative Bacteria; Humans; Kanamycin; Klebsiella; Microbial Sensitivity Tests; Prospective Studies; Pseudomonas aeruginosa; Time Factors; Tobramycin | 1986 |
Nosocomial consequences of antibiotic usage.
Topics: Amikacin; Bacteriuria; Cross Infection; Drug Resistance, Microbial; Drug Utilization; Gentamicins; Greece; Hospitals, General; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies | 1986 |
Imipenem/cilastatin in the treatment of severe hospital infections.
Topics: Adult; Aged; Amikacin; Cilastatin; Cross Infection; Cyclopropanes; Dipeptidases; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Thienamycins | 1988 |
Mechanisms of transferable amikacin resistance in enterobacteria in a Czechoslovak clinic.
Topics: Amikacin; Child, Preschool; Cross Infection; Czechoslovakia; Drug Resistance, Microbial; Enterobacteriaceae; Humans | 1988 |
Comparative efficacy of ceftazidime vs. carbenicillin and amikacin for treatment of neonatal septicemia.
Topics: Amikacin; Bacteria; Blood Bactericidal Activity; Carbenicillin; Ceftazidime; Cross Infection; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Male; Penicillin Resistance; Recurrence; Sepsis | 1987 |
[Aminoside sensitivity of bacteria isolated in 1984 at the military hospital complex in the Paris region].
Topics: Acinetobacter; Amikacin; Aminoglycosides; Cross Infection; Enterobacteriaceae; Gentamicins; Hospitals, Military; Humans; Microbial Sensitivity Tests; Netilmicin; Paris; Pseudomonas; Sisomicin; Tobramycin | 1987 |
Gentamicin resistance among gram-negative bacillary blood isolates in a hospital with long-term use of gentamicin.
Topics: Amikacin; Cross Infection; Drug Resistance, Microbial; Escherichia coli; Gentamicins; Humans; Klebsiella pneumoniae; Proteus mirabilis; Sepsis; Serratia marcescens | 1987 |
Sensitivity of hospital strains to amikacin.
Topics: Amikacin; Bacteria; Cross Infection; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests | 1987 |
Plasmid-encoded amikacin resistance in multiresistant strains of Klebsiella pneumoniae isolated from neonates with meningitis.
Topics: Acetyltransferases; Amikacin; Ampicillin; Cerebrospinal Fluid; Conjugation, Genetic; Cross Infection; DNA, Bacterial; Electrophoresis, Agar Gel; Escherichia coli; Humans; Infant, Newborn; Kanamycin; Klebsiella Infections; Klebsiella pneumoniae; Meningitis; Nucleic Acid Hybridization; Penicillin Resistance; R Factors; Tobramycin | 1986 |
Clinical experience with Timentin in severe hospital infections.
Topics: Acute Disease; Adolescent; Adult; Aged; Amikacin; Bacteria; Bacterial Infections; Clavulanic Acids; Cross Infection; Drug Combinations; Drug Evaluation; Drug Therapy, Combination; Female; Hemorrhagic Disorders; Humans; Male; Middle Aged; Pancreatitis; Penicillin Resistance; Penicillins; Ticarcillin | 1986 |
Amikacin synergism with beta-lactam antibiotics against selected nosocomial pathogens.
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; beta-Lactams; Cross Infection; Drug Resistance, Microbial; Drug Synergism; Gram-Negative Bacteria; Humans; Kanamycin; Microbial Sensitivity Tests | 1986 |
Management of sepsis in the elderly.
Topics: Aged; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Cross Infection; Drug Therapy, Combination; Female; Humans; Male; Pneumonia; Risk; Shock, Septic; Urinary Tract Infections | 1986 |
Upper and lower urinary tract infections: amikacin's role in managing surgical complications.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Drug Therapy, Combination; Humans; Kanamycin; Postoperative Complications; Premedication; Risk; Surgical Wound Infection; Urinary Catheterization; Urinary Tract Infections | 1986 |
Prevalence and mechanisms of aminoglycoside resistance. A ten-year study.
Topics: Acinetobacter; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Gentamicins; Humans; Microbial Sensitivity Tests; Pseudomonas; Staphylococcus aureus; Tobramycin | 1986 |
Synergy between amikacin and ticarcillin or mezlocillin against nosocomial bloodstream isolates.
Topics: Amikacin; Bacteria; Cross Infection; Drug Synergism; Humans; Mezlocillin; Penicillins; Ticarcillin | 1986 |
A one year survey on the epidemiology of aminoglycoside resistance in a general hospital: influence of amikacin.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Staphylococcus aureus | 1986 |
Three-year experience with amikacin sulfate as an exclusive surgical aminoglycoside in a large acute-care hospital.
Topics: Abdomen; Abscess; Amikacin; Ampicillin; Cefazolin; Clindamycin; Cross Infection; Drug Administration Schedule; Drug Therapy, Combination; Drug Utilization; Gentamicins; Gram-Negative Bacteria; Hospital Bed Capacity, 500 and over; Hospitals, Veterans; Humans; Kanamycin; Male; Middle Aged; Minnesota; Penicillin Resistance; Peritonitis; Postoperative Complications; Premedication; Surgical Wound Infection | 1985 |
Overview of first-line amikacin therapy for urologic infections.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cost-Benefit Analysis; Cross Infection; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Kanamycin; Kidney Diseases; Lactams; Sepsis; Urinary Tract Infections | 1985 |